| Name: |
|
| Other Names: |
|
|
Classification:
|
- Hormone; uterine stimulant; oxytocic; uterotonic
|
|
Mechanism of Action:
|
- Selectively stimulates the smooth musculature of the uterus, resulting in increased uterine muscle tone and increased frequency and strength of contractions
|
|
Indications:
|
- Post-partum hemorrhage
- Normal postpartum, after delivery of placenta
|
|
Contraindications:
|
- Do not administer to patients that have had uterine or cervical surgery
|
|
Precautions:
|
- May cause placental retention if given before delivery of the placenta
|
|
Adverse Effects:
|
- In mother
- Hypotension, dysrhythmias, tachycardia, seizures, coma, N/V, may have ADH effects at higher doses – water retention and vasoconstriction
- In the fetus
- Hypoxia, asphyxia, arrhythmias, intracranial bleeding
|
|
Dose:
|
- 20 - 30 Units IV infusion in 1000 ml NS @ 250 ml/hr (titrated to uterine response and severity of bleeding)
- 10 Units IM is an optional dosage regime
|
| Routes: |
|
| References: |
- Compendium of Pharmaceuticals and Specialties (CPS)
- Pharmacology for the Prehospital Provider 2nd Edition
|
Last modified: Wednesday, 26 March 2025, 4:33 PM